Cancer BiologybioRxivPreprint
Combination of Volasertib and Rapamycin Inhibits the Regrowth of TSC2-Deficient Tumors
M. Valianou, E. Y. Zhang, D. L. Johnson…·A. Astrinidis
This study shows that combining volasertib and rapamycin inhibits tumor regrowth in TSC2-deficient models more effectively than rapamycin alone.
DOI 10.1101/2022.11.02.512640